Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K, Okamoto T, Yokota S, Watanabe A, Horikoshi Y, Asami K, Kikuta A, Hyakuna N, Saikawa Y, Ueyama J, Watanabe T, Okada M, Taga T, Kanegane H, Kogawa K, Chin M, Iwai A, Matsushita T, Shimomura Y, Hori T, Tsurusawa M; Japanese Childhood Cancer Leukemia Study Group.
Yamaji K, et al. Among authors: horikoshi y.
Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95. doi: 10.1002/pbc.22620.
Pediatr Blood Cancer. 2010.
PMID: 20535816
Clinical Trial.